Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US5521219A · kind A · utility
35Cited by
14References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 1993 |
| Grant date | May 28, 1996 |
| Priority date | — |
| Expiry date | Aug 24, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C317/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Sulfonamide-containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.